1f4f: Difference between revisions

Revision as of 02:40, 1 July 2008

This article has been automatically seeded. Changes to this page should pertain to the PDB entry only and not to the protein or biomolecule in general.

File:1f4f.png

Template:STRUCTURE 1f4f

CRYSTAL STRUCTURE OF E. COLI THYMIDYLATE SYNTHASE COMPLEXED WITH SP-722CRYSTAL STRUCTURE OF E. COLI THYMIDYLATE SYNTHASE COMPLEXED WITH SP-722

Template:ABSTRACT PUBMED 10944209

About this StructureAbout this Structure

1F4F is a Single protein structure of sequence from Escherichia coli. Full crystallographic information is available from OCA.

ReferenceReference

Site-directed ligand discovery., Erlanson DA, Braisted AC, Raphael DR, Randal M, Stroud RM, Gordon EM, Wells JA, Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9367-72. PMID:10944209

Page seeded by OCA on Tue Jul 1 02:40:15 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-[[Image:1f4f.jpg|left|200px]]
+{{Seed}}
+[[Image:1f4f.png|left|200px]]
 <!--
@@ Line 9: / Line 10: @@
 {{STRUCTURE_1f4f|  PDB=1f4f  |  SCENE=  }}
-'''CRYSTAL STRUCTURE OF E. COLI THYMIDYLATE SYNTHASE COMPLEXED WITH SP-722'''
+===CRYSTAL STRUCTURE OF E. COLI THYMIDYLATE SYNTHASE COMPLEXED WITH SP-722===
-==Overview==
+<!--
-We report a strategy (called "tethering") to discover low molecular weight ligands ( approximately 250 Da) that bind weakly to targeted sites on proteins through an intermediary disulfide tether. A native or engineered cysteine in a protein is allowed to react reversibly with a small library of disulfide-containing molecules ( approximately 1,200 compounds) at concentrations typically used in drug screening (10 to 200 microM). The cysteine-captured ligands, which are readily identified by MS, are among the most stable complexes, even though in the absence of the covalent tether the ligands may bind very weakly. This method was applied to generate a potent inhibitor for thymidylate synthase, an essential enzyme in pyrimidine metabolism with therapeutic applications in cancer and infectious diseases. The affinity of the untethered ligand (K(i) approximately 1 mM) was improved 3,000-fold by synthesis of a small set of analogs with the aid of crystallographic structures of the tethered complex. Such site-directed ligand discovery allows one to nucleate drug design from a spatially targeted lead fragment.
+The line below this paragraph, {{ABSTRACT_PUBMED_10944209}}, adds the Publication Abstract to the page
+(as it appears on PubMed at http://www.pubmed.gov), where 10944209 is the PubMed ID number.
+-->
+{{ABSTRACT_PUBMED_10944209}}
 ==About this Structure==
@@ Line 31: / Line 35: @@
 [[Category: Wells, J A.]]
 [[Category: Crystal structure of e. coli thymidylate synthase complexed with sp-722]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May  2 15:53:10 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul  1 02:40:15 2008''